Antitumor active monofunctional platinum(II) complexes: Synthesis, structural characterization and reactivity towards biomolecules
Graphical abstract
Section snippets
Acknowledgements
We thank the financial supports from the National Natural Science Foundation of China (Nos. 20231010, 20228102 and 30370351) and the Natural Science Foundation of Jiangsu Province (No. BK 2005209).
References (22)
- et al.
Bioinorg. Chem.
(1973) Comments Inorg. Chem.
(1995)et al.Nucleic Acids Res.
(1996)- et al.
Cancer Res.
(1988) - et al.
Int. J. Pharm.
(2001)et al.Biochim. Biophys. Acta
(1999) - et al.
Curr. Med. Chem.
(2005) - et al.
Chem. Rev.
(1999) - et al.
Expert Opin. Pharmacother.
(2003) - et al.
Int. J. Cancer
(1995)Met. Ions Biol. Syst.
(1996)et al.(1999) Coordin. Chem. Rev.
(1997)- et al.
J. Med. Chem.
(1989)
J. Med. Chem.
Cited by (25)
New platinum(II)-based DNA intercalator: Synthesis, characterization and anticancer activity
2019, Inorganic Chemistry CommunicationsSynthesis, X-ray structure and in vitro cytotoxicity of trans-diammineplatinum(II) complexes of selenones, trans-[Pt(NH<inf>3</inf>)<inf>2</inf>(selenone)<inf>2</inf>](NO<inf>3</inf>)<inf>2</inf>
2019, PolyhedronCitation Excerpt :The platinum complexes in clinical use are usually characterized by cis geometry and leaving groups of intermediate strength [1–10]. In an attempt to develop more effective anticancer agents and to overcome the limitations of the existing platinum drugs, several trans and monofunctional complexes were also investigated, which were found to exhibit remarkable activity particularly against cisplatin-resistant cells [23–36]. Among the monofunctional compounds, pyriplatin (cis-[Pt(NH3)2(pyridine)Cl]Cl) [24,25] and phenanthriplatin (cis-[Pt(NH3)2(phenanthridine)Cl]NO3) [26] represent the lead compounds of this type.
In vitro anticancer activity evaluation of new cationic platinum(II) complexes based on imidazole moiety
2017, Bioorganic and Medicinal ChemistryCitation Excerpt :Breaking the assumption that bifunctionality is necessary for antiproliferative activity, monofunctional platinum complexes are emerging as a valid approach for circumvent the shortcomings of bifunctional platinum based drugs.11,12 Since the discovery of the potent antiproliferative activity of the platinum triamine complex phenanthriplatin and of its analogues,13 the mechanism of action of monofuntional platinum compounds as anticancer agents have been deeply investigated.14–16 This class of platinum complexes bearing only one labile ligand is able to form only a single covalent bond at the N7 position of guanine residues without significantly bending or unwinding the double helix but indeed forming lesions of such a shape that result able to elude cellular repair responses and to potentially interact with other-than-DNA targets, thus affording a novel activity profile.17,18
Synthesis, structural characterization, DNA/protein binding and in vitro cytotoxicity of three structurally different organoruthenium metallates from single pot
2016, Journal of Organometallic ChemistryDNA(CT), protein(BSA) binding studies, anti-oxidant and cytotoxicity studies of new binuclear Ni(II) complexes containing 4(N)-substituted thiosemicarbazones
2016, Inorganica Chimica ActaCitation Excerpt :In addition to study the interaction of metal complexes with DNA, it is also equally important to study the binding behaviour of metal complexes with albumin proteins because of the fact that many drugs, including anticancer, anti-inflammatory, and general anesthetics, are transported in the blood by combining with serum albumin [34]. The studies on interaction of protein with metal complexes can provide information of the structural features that determine the therapeutic effectiveness of the complex and have become an interesting field in recent years [35]. Therefore, it is absolutely essential and interest to study the interaction behaviors of the metal complexes with DNA and protein (bovine serum albumin).